Home > Healthcare > Pharmaceuticals > Finished Drug Form > U.S. Medical Marijuana Market
U.S. Medical Marijuana Market Share
- Report ID: GMI2890
- Published Date: Oct 2022
- Report Format: PDF
U.S. Medical Marijuana Market Share
Some of the leading companies in the U.S. medical marijuana market are:
- Aurora Cannabis Inc
- GW Pharmaceuticals
- Cannabis Sativa Inc
- Emerald Health Therapeutics Inc
- The Cronos Group Inc
- Tilray
- Lexaria Bioscience Corp
- Curaleaf
- Green Roads
- CHARLOTTE’S WEB
- Canopy Growth Corporation
- Gaia Herbs
- Medical Marijuana
- Folium Biosciences.
These companies are focusing on product commercialization and patents by means of collaboration with related firms.
Frequently Asked Questions (FAQ) :
U.S. market for medical marijuana was valued at over USD 9 billion in 2021 and is projected to expand at more than 10% CAGR between the estimated timeframe of 2022-2030.
Pain management applications was over USD 7 billion in 2021 due to the rise in the number of patients with chronic and neuropathic pain in the U.S.
South Atlantic U.S. medical marijuana market size is anticipated to exceed USD 3 billion by 2030 owing to increasing efforts to boost the production of cannabis products.
Tilray, Curaleaf, Green Roads, CHARLOTTE’S WEB, Gaia Herbs, Medical Marijuana, and Folium Biosciences are some of the leading companies in the U.S. market.
U.S. Medical Marijuana Market Scope
×
Get a free sample of
U.S. Medical Marijuana Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below